Revolution Medicines, Inc.RVMD

Where RVMD's P/E ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$205.11+1.34 (+0.66%)Previous close
NASDAQHealthcare

RVMD P/E ratio: current value, 10-year range and year-by-year history

-23.2Near historic low

RVMD's p/e ratio is lower than 95% of the last 10 years.

P/E ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
RVMD P/E ratio historyRVMD P/E ratio from Sep 2023 to Sep 2026: low -27.09, high -5.81, latest -23.15.-28.79-22.62-16.45-10.28-4.1Sep 23Apr 24Nov 24Jul 25Feb 26Sep 26med -11.23

RVMD P/E ratio by year

Yearly range of RVMD’s p/e ratio from 2020 to 2026. Over the full period it ranged from -27.1 to -5.2, averaging -12.7.

RVMD P/E ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
2026-27.1-19.8-13.2-23.2
2025-15.7-10.5-7.7-13.4
2024-16.9-11.1-7.2-12.2
2023-11.5-8.4-5.8-9.1
2022-10.3-7.4-5.2-7.5
2021-26.3-16.3-9.8-9.8
2020-26.0-18.3-11.6-19.1

Get notified when RVMD P/E ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.

FormulaPrice / Earnings Per Share
Full guide
How to read this chart

The chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.

Key caveats
  • Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
  • A falling P/E trend may signal a business in structural decline, not a buying opportunity.

Is RVMD P/E ratio High or Low Right Now?

Revolution Medicines, Inc.'s P/E ratio is currently -23.2, which is near historic low relative to its 10-year historical range. The 10-year median P/E ratio for RVMD is approximately -11.2. See all RVMD valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.